These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8849256)

  • 21. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.
    Fitoussi F; Doit C; Sandin A; Pechinot A; Kazmierczack A; Geslin P; Bingen E
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2560-3. PubMed ID: 8585745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Mohler J; Bédos JP
    Antimicrob Agents Chemother; 2004 Jan; 48(1):80-5. PubMed ID: 14693522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
    Woodnutt G; Berry V
    Antimicrob Agents Chemother; 1999 Jan; 43(1):35-40. PubMed ID: 9869562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin.
    Knudsen JD; Frimodt-Møller N; Espersen F
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1253-8. PubMed ID: 7574511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.
    Pankuch GA; Davies TA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2002 Jan; 46(1):42-6. PubMed ID: 11751109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.
    Gracia M; Martínez-Marín C; Huelves L; Giménez MJ; Aguilar L; Carcas A; Ponte C; Soriano F
    Antimicrob Agents Chemother; 2005 Mar; 49(3):996-1001. PubMed ID: 15728894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
    Fuursted K; Knudsen JD; Petersen MB; Poulsen RL; Rehm D
    Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.
    Chavanet P; Dalle F; Delisle P; Duong M; Pechinot A; Buisson M; D'Athis P; Portier H
    J Antimicrob Chemother; 1998 Feb; 41(2):237-46. PubMed ID: 9533466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model.
    Gustafsson I; Löwdin E; Odenholt I; Cars O
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2436-40. PubMed ID: 11502511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
    Barakett V; Lesage D; Delisle F; Guidet B; Burghoffer B; Richard G; Offenstadt G; Vergez P; Petit JC
    Pathol Biol (Paris); 1992 May; 40(5):483-91. PubMed ID: 1495831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.
    Piroth L; Martin L; Coulon A; Lequeu C; Duong M; Buisson M; Portier H; Chavanet P
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2484-92. PubMed ID: 10508029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
    Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
    J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
    Ponte C; Parra A; Nieto E; Soriano F
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2698-702. PubMed ID: 9124825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae.
    Martín M; Gómez-Lus ML; Aguilar L; Martínez P; Giménez MJ; Prieto J
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):512-6. PubMed ID: 9272386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain.
    Cafini F; del Campo R; Alou L; Sevillano D; Morosini MI; Baquero F; Prieto J;
    J Antimicrob Chemother; 2006 Feb; 57(2):224-9. PubMed ID: 16368701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
    Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.